rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-3-25
|
pubmed:abstractText |
To operationalize the measurement and interpretation of pharmaceutical underutilization using private insurance medical and drug claims data. This study also examined the relationship between underutilization of pharmaceuticals and patient outcomes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1086-5802
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
NS37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
511-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9479401-Aged,
pubmed-meshheading:9479401-Chronic Disease,
pubmed-meshheading:9479401-Drug Utilization Review,
pubmed-meshheading:9479401-Female,
pubmed-meshheading:9479401-Humans,
pubmed-meshheading:9479401-Insurance, Pharmaceutical Services,
pubmed-meshheading:9479401-Insurance Claim Review,
pubmed-meshheading:9479401-Male,
pubmed-meshheading:9479401-Middle Aged,
pubmed-meshheading:9479401-Treatment Refusal,
pubmed-meshheading:9479401-United States
|
pubmed:articleTitle |
Impact of pharmaceutical underutilization: a study of insurance drug claims data.
|
pubmed:affiliation |
Mikalix & Company, Waltham, Mass., USA. brookeh@neri.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|